SandboxAQ Partners with Mayo Clinic to Advance Cardiac Diagnostics

The collaboration will focus on SandboxAQ’s MCG imaging system, named CardiAQ. This system employs cutting-edge magnetic sensors and AI algorithms to offer a mobile, non-invasive method for cardiac imaging. 

SandboxAQ, a B2B company specializing in AI solutions, has collaborated with Mayo Clinic to explore advanced magnetocardiography (MCG) technology aimed at improving cardiac diagnostics. 

This partnership seeks to address the ongoing challenge of cardiovascular diseases, a leading cause of death globally.

The collaboration will focus on SandboxAQ’s MCG imaging system, named CardiAQ. This system employs cutting-edge magnetic sensors and AI algorithms to offer a mobile, non-invasive method for cardiac imaging. 

The initial phase of the project involves a clinical research study at Mayo Clinic’s Rochester, MN, facility. Further, the study will assess the relationship between CardiAQ’s MCG results and traditional angiography findings.

Kit Yee Au-Yeung, director of SandboxAQ’s medical devices division, said, “This collaboration between Mayo Clinic and SandboxAQ will further this breakthrough MCG technology for cardiac diagnostics. Cardiac disease is the leading cause of death globally and novel methods to easily and accurately diagnose disease are urgently needed.”

Benefits of CardiAQ

CardiAQ aims to enhance the speed and accuracy of cardiac diagnostics by utilizing high-performance sensors to detect minute variations in the heart's magnetic field. 

The system's advanced AI algorithms help filter out electromagnetic interference, potentially leading to improved detection of abnormal cardiac patterns and other indicators of heart disease. The technology is designed to be mobile and requires no specialized space, cooling, or shielding for operation.

The study will run throughout 2024 and 2025 and build on earlier successful trials conducted at UCSF Medical Center and Mount Sinai West Medical Center. CardiAQ is noted for its rapid measurement capability and ease of use in various clinical settings.

SandboxAQ’s CardiAQ could provide a more accessible and cost-effective alternative to traditional cardiac imaging methods, often involving high costs and radiation exposure. 

By offering a non-invasive and radiation-free option, CardiAQ may bridge the gap between inexpensive tests such as EKGs and costly procedures such as CT scans and invasive angiography.